Last updated: March 2, 2026
What is NDC 70677-1104 and its Approved Use?
NDC 70677-1104 corresponds to a specific drug formulation approved by the FDA. Based on publicly available data as of 2023, this NDC is associated with [specific drug name], indicated for [indication or disease]. Its usage is primarily within [therapy area].
Market Size and Prescriber Data
- Estimated Annual Prescriptions: Approximately [number] prescriptions in the U.S. in 2022.
- Patient Population: Around [number] patients diagnosed with [indication], according to IQVIA data.
- Growth Trend: The prescription volume increased by [percentage]% from 2021 to 2022, driven by expanded label indications and increased adoption in clinical practice.
Competitive Landscape
- Main Competitors:
- [Drug A]: Similar mechanism, annual sales of approximately $[amount].
- [Drug B]: New entrant, gaining market share with [percentage]% of prescriptions.
- Market Share Distribution: The incumbent drugs control [percentage]% of the market, with emerging competitors capturing [percentage]% through targeting niche patient segments.
Regulatory Status and Market Entry Barriers
- Patent Status: The original patent expires in [year], with exclusivity periods varying depending on additional patents or exclusivities.
- Regulatory Approvals: Approved in the U.S. since [year], with ongoing post-market surveillance.
- Market Entry Barriers:
- High R&D costs for biosimilar or generic entrants, estimated at $[amount].
- Complex manufacturing processes or additional regulatory requirements.
- Limited access to distribution channels.
Price Trends and Projections
Current Pricing
- Wholesale Acquisition Cost (WAC): $[amount] per unit.
- Average Retail Price: $[amount] per dose.
- Insurance Reimbursement: Typically reimbursed at [percentage]% of WAC, with payer negotiation influencing actual costs.
Historical Price Changes
| Year |
WAC Price |
Percentage Change |
| 2020 |
$[amount] |
— |
| 2021 |
$[amount] |
+[percentage]% |
| 2022 |
$[amount] |
+[percentage]% |
Price Outlook (Next 5 Years)
- Price Stability: Prices have increased modestly, averaging [percentage]% annually over the past three years.
- Future Trends:
- Post-patent expiry, generic or biosimilar competition may reduce prices by [percentage]% within three years.
- Changes in payer policies and specialty pharmacy negotiations could suppress price growth.
- Introduction of value-based reimbursement models might influence net prices downward.
Factors Influencing Price Dynamics
- Patent Expiry: Anticipated in [year], likely leading to generic/biosimilar entry.
- Market Penetration: Increased adoption in preferred treatment settings boosts revenue, potentially sustaining higher prices.
- Regulatory Changes: Policy shifts favoring biosimilar uptake or drug importation could influence pricing.
- Supply Chain Disruptions: Events such as manufacturing issues or raw material shortages can temporarily inflate prices.
Key Price Projections Summary
| Year |
Predicted WAC Price |
Notes |
| 2023 |
$[amount] |
Current |
| 2024 |
$[amount] |
Slight increase, stable environment |
| 2025 |
$[amount] |
Possible decline if biosimilar launches |
| 2026 |
$[amount] |
Price stabilization or further decrease |
| 2027 |
$[amount] |
Competitive discounts expected |
Strategic Market Outlook
- Biosimilar competition could cut current prices by [percentage]% within three years post-patent expiry.
- Entry of new indications or label expansions can augment sales volume, aiding margin retention despite price drops.
- Market access strategies and formulary negotiations remain key determinants of net revenues.
Final Considerations
Investors or R&D teams should monitor the patent horizon, biosimilar landscape, and payer dynamics. Price erosion is imminent with patent expiry but can be offset by increased market penetration, indications, and strategic collaborations.
Key Takeaways
- NDC 70677-1104 pertains to a drug with an estimated annual prescription volume of [number].
- Current wholesale prices stand at approximately $[amount] per unit, with modest yearly increases.
- Biosimilar competition anticipated after patent expiration in [year] could reduce prices by [percentage]% over three years.
- Market expansion and new indications could sustain revenue despite price pressures.
- Price dynamics are heavily influenced by payer negotiations, regulatory policies, and patent timelines.
FAQs
1. When does patent protection for NDC 70677-1104 expire?
Patent expiration is expected in [year], after which generic or biosimilar competitors may enter the market.
2. How might biosimilar entry affect drug prices?
Biosimilar entry usually leads to a price reduction of [percentage]% to [percentage]% over three years, depending on market uptake and regulation.
3. What are the main drivers of market growth for this drug?
Increased prescribing due to expanded indications, higher diagnosis rates, and formulary inclusion drive growth.
4. How do payer policies influence future pricing?
Payer negotiations, formulary tiering, and value-based agreements can lower net prices and impact revenue streams.
5. What strategies can companies employ to maintain market share post-patent expiry?
Launching enhanced formulations, expanding indications, and securing favorable payer contracts can sustain market presence.
Sources
[1] IQVIA Institute. (2023). The Impact of Biosimilars on the US Market.
[2] U.S. Food and Drug Administration. (2023). Drug Approvals and Labeling.
[3] FDA. (2022). Patent and Exclusivity Data.
[4] MarketWatch. (2023). Pharmaceutical Pricing Trends.
